Download a Free Sample To learn more about this report,
The Canada cardiac imaging software market size was valued at USD 342 million in 2025 and is projected to grow from USD 371 million in 2026 to reach USD 746 million by 2034, growing at a CAGR of 9.15% during the forecast period 2026–2034. This growth is driven by advancements in diagnostic technologies, increasing prevalence of cardiovascular disease (CVD), and rising investments in healthcare infrastructure.
The increasing prevalence of cardiovascular diseases is a critical driver of the market. According to the Canadian Cardiovascular Society (CCS), CVDs account for nearly 27% of deaths annually, emphasizing the urgent need for advanced diagnostic solutions. The aging population further exacerbates this trend, with older adults being more prone to heart-related ailments.
Additionally, technological advancements, such as AI-enabled software, have revolutionized cardiac imaging by improving accuracy and reducing diagnostic time.
Despite significant advancements, the high cost of this software remains a substantial barrier. MRI systems and specialized software entail considerable investment, with prices ranging from CAD 1–2 million, making it challenging for smaller clinics to adopt these technologies. While government subsidies and health insurance cover some of these expenses, the financial burden on healthcare providers in rural and underserved areas persists.
Additionally, accessibility to advanced systems is uneven across Canada. Rural and remote regions face challenges due to limited healthcare infrastructure and a shortage of skilled radiologists, leading to diagnostic delays. Addressing these disparities through targeted policies and investments is crucial for equitable market growth.
The integration of Artificial Intelligence (AI) and cloud-based solutions presents significant growth opportunities in the Canadian market. AI-powered software enables precise diagnosis, predictive analytics, and personalized treatment planning, transforming patient care. According to a report by the Canadian Institute for Health Information (CIHI), the adoption of AI in healthcare is expected to grow exponentially, aligning with the government’s Digital Health Strategy.
Moreover, cloud-based imaging solutions offer scalability and real-time access to patient data, enhancing collaboration among healthcare providers. For example, platforms developed by vendors like Philips Healthcare allow seamless data sharing across hospitals and diagnostic centers, improving workflow efficiency. These innovations cater to Canada’s growing demand for digital health solutions, ensuring the market’s sustained expansion.
Magnetic resonance imaging dominates the modality segment and is expected to grow at a CAGR of 9.4% over the forecast period. MRI’s non-invasive nature and superior image quality make it indispensable for cardiac diagnostics. Innovations like 4D flow MRI and AI integration enhance diagnostic accuracy, catering to complex conditions like congenital heart defects and ischemic heart disease.
Diagnostic imaging leads the application segment and is expected to grow at a CAGR of 8.1% during the forecast period. The increasing need for early detection of cardiac anomalies fuels this growth. The rising adoption of stress echocardiography and nuclear cardiology techniques further supports this segment’s expansion.
Hospitals dominate the end-user segment and are expected to grow at a CAGR of 9.0% over the forecast period. Tertiary care facilities in urban centers are increasingly equipped with state-of-the-art imaging technologies, addressing the high patient influx. Government investments in public hospitals under initiatives like Canada’s Healthcare Infrastructure Program bolster this segment’s growth.
Request Customizationto receive a tailored report.
Speak to an Analystto discuss market opportunities.
The market is characterized by regional disparities in healthcare infrastructure, technological adoption, and urbanization. Key cities such as Toronto, Vancouver, Montreal, Calgary, and Ottawa play pivotal roles in driving growth.
Toronto, as Canada’s financial and healthcare hub, spearheads the adoption of cardiac imaging technologies. Institutions like the Toronto General Hospital leverage advanced systems for cutting-edge cardiac care. Collaborations with global medtech companies foster innovation and accessibility.
Vancouver’s emphasis on integrating AI into healthcare accelerates market growth. Hospitals like St. Paul’s have AI-powered imaging systems, ensuring precise diagnostics. The city’s strong focus on preventive healthcare aligns with the increasing demand for advanced cardiac imaging.
Montreal boasts a robust network of healthcare facilities specializing in cardiovascular care. Research institutions like the Montreal Heart Institute lead clinical trials for next-generation imaging solutions, driving regional advancements.
Calgary’s burgeoning healthcare infrastructure supports the adoption of innovative technologies. Partnerships between local health authorities and global companies ensure the availability of cost-effective diagnostic tools catering to the city’s diverse population.
Ottawa’s strategic focus on digital healthcare transformation enhances the adoption of cloud-based imaging solutions. The city’s advanced diagnostic centers, backed by government funding, are critical in reducing wait times and improving patient outcomes.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Severity: Notice
Message: Undefined variable: relatedReports
Filename: reportpages/rd.php
Line Number: 640
Backtrace:
File: /var/www/html/application/views/frontend/reportpages/rd.php Line: 640 Function: _error_handler
File: /var/www/html/application/controllers/FrontendRegionalReportController.php Line: 108 Function: view
File: /var/www/html/index.php Line: 364 Function: require_once
We are featured on:
sales@straitsresearch.com